Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salbutamol sulfate |
Is a |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol measurement |
Component |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol [inhalation preparations 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterolpræparat til inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol poisoning (disorder) |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Accidental salbutamol poisoning |
Causative agent |
False |
Salbutamol |
Inferred relationship |
Some |
|
Intentional salbutamol poisoning |
Causative agent |
False |
Salbutamol |
Inferred relationship |
Some |
|
forgiftning med salbutamol, uvist med hvilken hensigt |
Causative agent |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol adverse reaction |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Allergy to salbutamol |
Causative agent |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol overdose |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Accidental salbutamol overdose |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Intentional salbutamol overdose |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
overdosis af salbutamol, uvist med hvilken hensigt |
Causative agent |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterol 4 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol kapsel med modificeret udløsning a 4 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol kapsel med modificeret udløsning a 8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 4 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 8 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 2 mg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 5 mg/50 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 250 µg/5 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 500 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 5 mg/5 ml infusionsvæske til intravenøs anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 200 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 400 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 200 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 400 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 100 µg indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 200 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 95 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 100 µg indåndingsudløst CFC-fri aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 5 mg/2,5 ml nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 100 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
fenoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 200 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 400 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 100 mg/20 ml opløsning til nebulisator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
salbutamol 100 µg + ipratropiumbromid 20 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
salbutamol 2,5 mg + ipratropiumbromid 500 µg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg + salbutamol 400 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg + salbutamol 200 µg pædiatrisk inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg + salbutamol 100 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
natriumcromoglycat + albuterol 1 mg/100 µg inhalator + spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
natriumcromoglycat 1 mg + albuterol 100 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol [obstetric] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
natriumcromoglycat + albuterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 200 µg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 0,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Albuterol sulfate 4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 90 µg inhalationsaerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterolsulfat 103 µg + ipratropiumbromid 18 µg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Product containing salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Albuterol+ipratropium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 100 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
albuterol 0,0417 % inhalationsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
|
Accidental salbutamol poisoning |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Intentional salbutamol poisoning |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing ipratropium and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing beclometasone and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Allergy to salbutamol |
Causative agent |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterol 4 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterol 4 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Salbutamol |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterol 4 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing cromoglicic acid and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/50 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/5 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only beclometasone and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing only cromoglicic acid and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Ipratropium and salbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing only salbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
albuterol 0,5 % opløsning |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |